Amneal Pharmaceuticals (AMRX) Asset Utilization Ratio (2018 - 2026)

Amneal Pharmaceuticals' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.84 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 2.38% year-over-year to 0.84 in Q1 2026; TTM through Mar 2026 was 0.84, a 2.38% increase from a year earlier, with the FY2025 full-year figure at 0.84, up 4.95% from the prior year.
• Asset Utilization Ratio rose to 0.84 in Q1 2026 per AMRX's latest filing, from 0.83 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.84 in Q1 2026 and bottomed at 0.01 in Q4 2022.
• The 5-year median for Asset Utilization Ratio is 0.72 (2024), against an average of 0.56.
• Across the five-year window, Asset Utilization Ratio tumbled 99.02% in 2022 and surged 12856.35% in 2023, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.01 in 2022, then jumped by 12856.35% to 0.67 in 2023, then increased by 20.03% to 0.8 in 2024, then gained by 3.36% to 0.83 in 2025, then grew by 1.73% to 0.84 in 2026.
• Per Business Quant, the three latest AMRX Asset Utilization Ratio figures stand at 0.84 (Q1 2026), 0.83 (Q4 2025), and 0.84 (Q3 2025).